120 related articles for article (PubMed ID: 25747602)
1. Changes in the expression of genes encoding for mGlu4 and mGlu5 receptors and other regulators of the indirect pathway in acute mouse models of drug-induced parkinsonism.
Cannella M; Motolese M; Bucci D; Molinaro G; Gradini R; Bruno V; Nicoletti F; Battaglia G
Neuropharmacology; 2015 Aug; 95():50-8. PubMed ID: 25747602
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
Morin N; Jourdain VA; Morissette M; Grégoire L; Di Paolo T
Neuropharmacology; 2014 Apr; 79():688-706. PubMed ID: 24456747
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
Morin N; Morissette M; Grégoire L; Gomez-Mancilla B; Gasparini F; Di Paolo T
Neuropharmacology; 2013 Oct; 73():216-31. PubMed ID: 23756168
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Battaglia G; Busceti CL; Molinaro G; Biagioni F; Traficante A; Nicoletti F; Bruno V
J Neurosci; 2006 Jul; 26(27):7222-9. PubMed ID: 16822979
[TBL] [Abstract][Full Text] [Related]
5. GPR55: A therapeutic target for Parkinson's disease?
Celorrio M; Rojo-Bustamante E; Fernández-Suárez D; Sáez E; Estella-Hermoso de Mendoza A; Müller CE; Ramírez MJ; Oyarzábal J; Franco R; Aymerich MS
Neuropharmacology; 2017 Oct; 125():319-332. PubMed ID: 28807673
[TBL] [Abstract][Full Text] [Related]
6. Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Battaglia G; Busceti CL; Molinaro G; Biagioni F; Storto M; Fornai F; Nicoletti F; Bruno V
J Neurosci; 2004 Jan; 24(4):828-35. PubMed ID: 14749427
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease.
Al-Sweidi S; Morissette M; Di Paolo T
J Steroid Biochem Mol Biol; 2016 Jul; 161():84-91. PubMed ID: 26873133
[TBL] [Abstract][Full Text] [Related]
8. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
[TBL] [Abstract][Full Text] [Related]
9. Localization and expression of group I metabotropic glutamate receptors in the mouse striatum, globus pallidus, and subthalamic nucleus: regulatory effects of MPTP treatment and constitutive Homer deletion.
Kuwajima M; Dehoff MH; Furuichi T; Worley PF; Hall RA; Smith Y
J Neurosci; 2007 Jun; 27(23):6249-60. PubMed ID: 17553998
[TBL] [Abstract][Full Text] [Related]
10. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
[TBL] [Abstract][Full Text] [Related]
11. Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei.
Meissner W; Dovero S; Bioulac B; Gross CE; Bezard E
Neurobiol Dis; 2003 Jun; 13(1):46-54. PubMed ID: 12758066
[TBL] [Abstract][Full Text] [Related]
12. Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats.
Lopez S; Turle-Lorenzo N; Johnston TH; Brotchie JM; Schann S; Neuville P; Amalric M
Neuropharmacology; 2008 Sep; 55(4):483-90. PubMed ID: 18625257
[TBL] [Abstract][Full Text] [Related]
13. Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action.
Gubellini P; Melon C; Dale E; Doller D; Kerkerian-Le Goff L
Neuropharmacology; 2014 Oct; 85():166-77. PubMed ID: 24866785
[TBL] [Abstract][Full Text] [Related]
14. Early life stress causes refractoriness to haloperidol-induced catalepsy.
Marrocco J; Mairesse J; Bucci D; Lionetto L; Battaglia G; Consolazione M; Ravasi L; Simmaco M; Morley-Fletcher S; Maccari S; Nicoletti F
Mol Pharmacol; 2013 Aug; 84(2):244-51. PubMed ID: 23716620
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys.
Kaneda K; Tachibana Y; Imanishi M; Kita H; Shigemoto R; Nambu A; Takada M
Eur J Neurosci; 2005 Dec; 22(12):3241-54. PubMed ID: 16367790
[TBL] [Abstract][Full Text] [Related]
16. Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.
Annese V; Herrero MT; Di Pentima M; Gomez A; Lombardi L; Ros CM; De Pablos V; Fernandez-Villalba E; De Stefano ME
Brain Struct Funct; 2015 Mar; 220(2):703-27. PubMed ID: 24558048
[TBL] [Abstract][Full Text] [Related]
17. Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Aubert I; Guigoni C; Li Q; Dovero S; Bioulac BH; Gross CE; Crossman AR; Bloch B; Bezard E
Biol Psychiatry; 2007 Apr; 61(7):836-44. PubMed ID: 16950226
[TBL] [Abstract][Full Text] [Related]
18. L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus.
Bonaventura J; Rico AJ; Moreno E; Sierra S; Sánchez M; Luquin N; Farré D; Müller CE; Martínez-Pinilla E; Cortés A; Mallol J; Armentero MT; Pinna A; Canela EI; Lluís C; McCormick PJ; Lanciego JL; Casadó V; Franco R
Neuropharmacology; 2014 Apr; 79():90-100. PubMed ID: 24230991
[TBL] [Abstract][Full Text] [Related]
19. The striopallidal pathway is involved in antiparkinsonian-like effects of the blockade of group I metabotropic glutamate receptors in rats.
Ossowska K; Wardas J; Pietraszek M; Konieczny J; Wolfarth S
Neurosci Lett; 2003 May; 342(1-2):21-4. PubMed ID: 12727308
[TBL] [Abstract][Full Text] [Related]
20. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
Betarbet R; Greenamyre JT
Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
